Atlas Trials

Ocuphire Pharma, Inc.

14 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Ocuphire Pharma, Inc.

RecordFirmDate
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (NCT07140783)Ocuphire Pharma, Inc.2025-09-02
Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia (NCT06542497)Ocuphire Pharma, Inc.2024-08-15
Safety and Efficacy of 0.75% Phentolamine Ophthalmic Solution in Subjects With Post-refractive Surgery Visual Disturbances (NCT06349759)Ocuphire Pharma, Inc.2024-04-01
Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia (NCT05646719)Ocuphire Pharma, Inc.2022-12-22
Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Subjects (NCT05223478)Ocuphire Pharma, Inc.2021-12-17
Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy (NCT04692688)Ocuphire Pharma, Inc.2021-04-08
Safety and Efficacy of Nyxol With Pilocarpine Eye Drops in Subjects With Presbyopia (NCT04675151)Ocuphire Pharma, Inc.2021-02-15
Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) in Subjects With Dim Light Vision Disturbances (NCT04638660)Ocuphire Pharma, Inc.2020-12-30
Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis (NCT04620213)Ocuphire Pharma, Inc.2020-11-18
Safety and Efficacy of Ophthalmic Phentolamine Mesylate to Reverse Pharmacologically Induced Mydriasis (NCT04024891)Ocuphire Pharma, Inc.2019-08-13
Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma (NCT03960866)Ocuphire Pharma, Inc.2019-05-28

Track Ocuphire Pharma, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.